Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward

Get the Details Now.

RGEN Insider Trading (Repligen)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $22,123,886.93

Repligen Insider Trading History Chart

Repligen Share Price & Price History

^$154.53

▼ -0.1 (-0.06%)

As of 05/20/2022 05:00 PM ET

Days: 30 | 90 | 365

BANNED?! The Greatest Moneymaking Opportunity Ever?

From Oxford Club | Ad

Politicians want to BAN one of the greatest moneymaking strategies ever.

But Alexander Green and Bill O'Reilly are going LIVE on June 9 to help you fight for the right to use it... so you can achieve financial independence.

Click here and reserve your seat for this FREE online event, before the spots are all taken!

>>>

Repligen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/1/2022	Thomas F. Ryan, Jr.	Director	Sell	2,000	$198.03	$396,060.00
11/18/2021	Anthony Hunt	CEO	Sell	17,355	$276.85	$4,804,731.75
11/4/2021	Thomas F. Ryan, Jr.	Director	Sell	1,000	$288.00	$288,000.00
11/2/2021	Karen A. Dawes	Director	Sell	2,400	$303.94	$729,456.00
10/29/2021	Nicolas Barthelemy	Director	Sell	1,645	$288.20	$474,089.00
9/14/2021	Karen A. Dawes	Director	Sell	274	$294.26	$80,627.24	93,908
9/9/2021	Anthony Hunt	CEO	Sell	25,000	$294.75	$7,368,750.00	214,495
8/30/2021	Ralf Kuriyel	VP	Sell	4,001	$282.13	$1,128,802.13
8/17/2021	Karen A. Dawes	Director	Sell	17,514	$253.77	$4,444,527.78	111,953
8/4/2021	Thomas F. Ryan, Jr.	Director	Sell	780	$250.50	$195,390.00
7/20/2021	Karen A. Dawes	Director	Sell	4,585	$202.09	$926,582.65
6/10/2021	Ralf Kuriyel	VP	Sell	6,802	$189.19	$1,286,870.38	27,112
5/19/2021	Anthony Hunt	CEO	Sell	22,267	$171.41	$3,816,786.47	212,150
5/14/2021	Christine Gebski	Insider	Sell	445	$172.25	$76,651.25	36,695
5/14/2021	Jon Snodgres	CFO	Sell	470	$172.60	$81,122.00	31,893
5/14/2021	Ralf Kuriyel	VP	Sell	710	$172.29	$122,325.90	24,555
5/11/2021	Karen A. Dawes	Director	Sell	285	$176.85	$50,402.25	115,734
4/6/2021	James Bylund	SVP	Sell	360	$204.25	$73,530.00	6,324
3/16/2021	Christine Gebski	Insider	Sell	1,400	$196.88	$275,632.00	37,140
3/12/2021	Anthony Hunt	CEO	Sell	9,102	$190.38	$1,732,838.76	220,950
3/10/2021	Ralf Kuriyel	VP	Sell	8,000	$190.44	$1,523,520.00	27,265
3/4/2021	Anthony Hunt	CEO	Sell	21,900	$190.19	$4,165,161.00	242,970
3/4/2021	Jon Snodgres	CFO	Sell	3,545	$192.47	$682,306.15	35,708
3/4/2021	Ralf Kuriyel	VP	Sell	2,075	$192.00	$398,400.00	26,940
3/3/2021	Thomas F. Ryan, Jr.	Director	Sell	1,000	$205.00	$205,000.00	2,464
1/4/2021	Jon Snodgres	CFO	Sell	3,957	$191.52	$757,844.64	32,799
12/16/2020	Ralf Kuriyel	VP	Sell	435	$186.18	$80,988.30	25,654
11/19/2020	Anthony Hunt	CEO	Sell	20,000	$185.80	$3,716,000.00	253,327
11/11/2020	Thomas F. Ryan, Jr.	Director	Sell	934	$187.73	$175,339.82	2,398
11/9/2020	Jon Snodgres	CFO	Sell	705	$194.69	$137,256.45	31,562
11/9/2020	Nicolas Barthelemy	Director	Sell	1,214	$195.51	$237,349.14	1,450
9/10/2020	Anthony Hunt	CEO	Sell	45,351	$148.20	$6,721,018.20	278,678
8/6/2020	Ralf Kuriyel	VP	Sell	5,000	$153.79	$768,950.00	31,089
7/31/2020	Thomas F. Ryan, Jr.	Director	Sell	3,095	$151.90	$470,130.50	4,559
6/18/2020	Karen A. Dawes	Director	Sell	18,705	$115.20	$2,154,816.00	116,762
5/21/2020	Anthony Hunt	CEO	Sell	46,953	$139.77	$6,562,620.81	238,157
5/20/2020	Karen A. Dawes	Director	Sell	517	$139.44	$72,090.48	119,946
5/18/2020	Karen A. Dawes	Director	Sell	1,600	$137.78	$220,448.00	121,556
5/15/2020	Jon Snodgres	CFO	Sell	660	$140.43	$92,683.80	32,267
5/15/2020	Ralf Kuriyel	VP	Sell	435	$140.69	$61,200.15	26,089
5/13/2020	Jon Snodgres	CFO	Sell	15,394	$128.74	$1,981,823.56	39,297
5/13/2020	Ralf Kuriyel	VP	Sell	8,000	$127.80	$1,022,400.00	32,524
4/22/2020	Nicolas Barthelemy	Director	Sell	2,688	$109.99	$295,653.12	5,725
4/20/2020	Karen A. Dawes	Director	Sell	12,200	$104.57	$1,275,754.00	121,234
4/3/2020	Nicolas Barthelemy	Director	Sell	2,688	$99.99	$268,773.12	6,761
3/24/2020	John Cox	Director	Sell	1,858	$96.72	$179,705.76	923
3/18/2020	John Cox	Director	Sell	26,736	$95.27	$2,547,138.72	16,781
3/4/2020	Thomas F. Ryan, Jr.	Director	Sell	4,796	$88.82	$425,980.72	1,923
3/3/2020	Anthony Hunt	CEO	Sell	2,190	$88.22	$193,201.80	242,641
3/3/2020	Jon Snodgres	CFO	Sell	610	$88.18	$53,789.80	37,172
3/3/2020	Ralf Kuriyel	VP	Sell	450	$88.35	$39,757.50	29,079
2/26/2020	Jon Snodgres	CFO	Sell	1,100	$86.22	$94,842.00	32,042
2/26/2020	Ralf Kuriyel	VP	Sell	195	$86.60	$16,887.00	26,313
2/25/2020	Anthony Hunt	CEO	Sell	11,735	$91.56	$1,074,456.60	231,148
2/24/2020	John Cox	Director	Sell	4,455	$92.81	$413,468.55	7,136
9/19/2019	Anthony Hunt	CEO	Sell	3,600	$82.89	$298,404.00	223,013
9/9/2019	Anthony Hunt	CEO	Sell	12,094	$82.40	$996,545.60	210,976
6/17/2019	Karen A. Dawes	Director	Sell	1,295	$77.35	$100,168.25	118,329
5/23/2019	Glenn L Md Cooper	Director	Sell	5,000	$66.94	$334,700.00	35,975

[Big Reveal] Secret Strategy Makes Investors "Very, Very Rich

From Oxford Club | Ad

Studies by Harvard, Vanderbilt, the U.S. Chamber of Commerce, Reuters, Fidelity and Deutsche Bank all confirm one simple strategy leads to outsized profits for investors.

Yet the elites in Washington want to ban this moneymaking method!

Join Alexander Green and Bill O'Reilly on June 9 at 8 p.m. ET to discover perhaps the greatest (yet controversial) profit strategy of our lifetimes.

>>>

SEC Filings (Institutional Ownership Changes) for Repligen (NASDAQ:RGEN)

86.82% of Repligen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Repligen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/20/2022	The Manufacturers Life Insurance Company	53,816	$10.13M	0.0%	-56.8%	0.099%
5/20/2022	Toroso Investments LLC	1,079	$0.20M	0.0%	+15.3%	0.002%
5/18/2022	BNP Paribas Arbitrage SA	12,804	$2.41M	0.0%	-26.4%	0.024%
5/17/2022	Walleye Capital LLC	2,305	$0.43M	0.0%	N/A	0.004%
5/17/2022	Weiss Multi Strategy Advisers LLC	8,960	$1.69M	0.0%	-35.7%	0.016%
5/17/2022	Advisors Asset Management Inc.	22,626	$4.26M	0.1%	-8.0%	0.042%
5/17/2022	Alyeska Investment Group L.P.	19,571	$3.68M	0.0%	N/A	0.036%
5/17/2022	Quantbot Technologies LP	988	$0.19M	0.0%	-85.7%	0.002%
5/17/2022	Select Equity Group L.P.	940,504	$176.90M	0.6%	-2.0%	1.728%
5/17/2022	Dynamic Technology Lab Private Ltd	4,220	$0.79M	0.1%	-60.2%	0.008%
5/17/2022	Eaton Vance Management	144,824	$27.24M	0.0%	+9.0%	0.266%
5/17/2022	Ensign Peak Advisors Inc	45,075	$8.48M	0.0%	+0.4%	0.083%
5/17/2022	Eqis Capital Management Inc.	6,283	$1.18M	0.1%	+14.9%	0.012%
5/17/2022	Farallon Capital Management LLC	222,979	$41.94M	0.2%	+63.7%	0.410%
5/17/2022	First Manhattan Co.	10,095	$1.90M	0.0%	+6.1%	0.019%
5/17/2022	First Republic Investment Management Inc.	20,165	$3.79M	0.0%	-25.4%	0.037%
5/17/2022	Gilder Gagnon Howe & Co. LLC	222,850	$41.92M	0.4%	-49.4%	0.409%
5/17/2022	Guggenheim Capital LLC	5,305	$1M	0.0%	-35.9%	0.010%
5/17/2022	Geneos Wealth Management Inc.	680	$0.13M	0.0%	-15.5%	0.001%
5/17/2022	12 West Capital Management LP	813,157	$152.95M	9.3%	+0.1%	1.494%
5/17/2022	1832 Asset Management L.P.	442,500	$82.17M	0.1%	-34.1%	0.813%
5/16/2022	California State Teachers Retirement System	68,302	$12.85M	0.0%	-8.0%	0.125%
5/16/2022	Goldman Sachs Group Inc.	393,951	$74.10M	0.0%	+1.6%	0.724%
5/16/2022	Journey Strategic Wealth LLC	1,229	$0.23M	0.0%	+16.1%	0.002%
5/16/2022	Captrust Financial Advisors	3,780	$0.71M	0.0%	+32.0%	0.007%
5/16/2022	Brinker Capital Investments LLC	1,477	$0.28M	0.0%	-13.8%	0.003%
5/16/2022	State Street Corp	1,381,031	$259.76M	0.0%	+2.5%	2.537%
5/16/2022	Ethic Inc.	2,559	$0.48M	0.0%	+31.1%	0.005%
5/16/2022	Echo Street Capital Management LLC	562,249	$105.75M	0.8%	+23.7%	1.033%
5/16/2022	Eversept Partners LP	36,521	$6.87M	0.6%	+696.7%	0.067%
5/16/2022	Harding Loevner LP	177	$26K	0.0%	+121.3%	0.000%
5/16/2022	LRT Capital Management LLC	26,982	$5.08M	3.2%	+61.5%	0.050%
5/16/2022	Atria Wealth Solutions Inc.	9,564	$1.80M	0.0%	N/A	0.018%
5/16/2022	Kensington Investment Counsel LLC	4,872	$0.92M	0.6%	-43.4%	0.009%
5/16/2022	Invesco Ltd.	1,756,157	$330.32M	0.1%	+3.9%	3.227%
5/16/2022	Granahan Investment Management LLC	23,475	$4.42M	0.1%	N/A	0.043%
5/16/2022	Hsbc Holdings PLC	1,984	$0.38M	0.0%	+61.2%	0.004%
5/13/2022	Renaissance Technologies LLC	220,816	$41.53M	0.0%	+25.0%	0.406%
5/13/2022	Northern Trust Corp	415,330	$78.12M	0.0%	-2.0%	0.763%
5/13/2022	Charles Schwab Investment Management Inc.	288,185	$54.21M	0.0%	+2.5%	0.529%
5/13/2022	Edgestream Partners L.P.	21,791	$4.10M	0.3%	-14.4%	0.040%
5/13/2022	Lazard Asset Management LLC	460	$86K	0.0%	-91.1%	0.001%
5/13/2022	Utah Retirement Systems	9,751	$1.83M	0.0%	-1.0%	0.018%
5/13/2022	Nelson Van Denburg & Campbell Wealth Management Group LLC	1,583	$0.30M	0.0%	N/A	0.003%
5/13/2022	First Trust Advisors LP	86,120	$16.20M	0.0%	-36.3%	0.158%
5/13/2022	Prudential Financial Inc.	16,416	$3.09M	0.0%	-4.2%	0.030%
5/13/2022	Federated Hermes Inc.	548,040	$103.08M	0.2%	-2.6%	1.007%
5/13/2022	American International Group Inc.	87,579	$16.47M	0.1%	+0.2%	0.161%
5/13/2022	Bridgewater Associates LP	2,992	$0.56M	0.0%	N/A	0.005%
5/13/2022	Pearl River Capital LLC	1,299	$0.24M	0.1%	-40.1%	0.002%
5/13/2022	Fuller & Thaler Asset Management Inc.	61,013	$11.48M	0.1%	+1.7%	0.112%
5/13/2022	Covestor Ltd	484	$91K	0.1%	+58.7%	0.001%
5/13/2022	Baird Financial Group Inc.	344,311	$64.76M	0.2%	+3.9%	0.633%
5/13/2022	Vanguard Group Inc.	4,891,604	$920.06M	0.0%	-0.4%	8.987%
5/13/2022	Cetera Investment Advisers	2,108	$0.40M	0.0%	+23.3%	0.004%
5/13/2022	Canada Pension Plan Investment Board	359,366	$67.59M	0.1%	+0.4%	0.660%
5/13/2022	Sei Investments Co.	59,917	$11.33M	0.0%	+18.5%	0.110%
5/13/2022	Lord Abbett & CO. LLC	188,971	$35.54M	0.1%	+18.6%	0.347%
5/13/2022	Blair William & Co. IL	2,835	$0.53M	0.0%	-14.4%	0.005%
5/13/2022	Dimensional Fund Advisors LP	229,785	$43.22M	0.0%	+5.1%	0.422%
5/12/2022	Raymond James Trust N.A.	2,331	$0.44M	0.0%	+37.4%	0.004%
5/12/2022	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	157,211	$29.57M	0.1%	-8.3%	0.289%
5/12/2022	Yousif Capital Management LLC	25,500	$4.80M	0.1%	-3.2%	0.047%
5/12/2022	Great West Life Assurance Co. Can	28,126	$5.43M	0.0%	+8.2%	0.052%
5/12/2022	D L Carlson Investment Group Inc.	12,655	$2.38M	0.4%	-10.0%	0.023%
5/12/2022	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	18,844	$3.54M	0.0%	+10.5%	0.035%
5/12/2022	Rhumbline Advisers	138,830	$26.11M	0.0%	-0.2%	0.255%
5/12/2022	Quantinno Capital Management LP	1,318	$0.25M	0.0%	N/A	0.002%
5/12/2022	Archer Investment Corp	365	$69K	0.0%	N/A	0.001%
5/12/2022	MetLife Investment Management LLC	35,625	$6.70M	0.0%	+43.0%	0.065%
5/12/2022	Dana Investment Advisors Inc.	6,794	$1.28M	0.1%	+45.4%	0.012%
5/12/2022	FORA Capital LLC	6,098	$1.15M	0.2%	N/A	0.011%
5/12/2022	Bank of Montreal Can	36,725	$6.93M	0.0%	+28.8%	0.067%
5/12/2022	Natixis Advisors L.P.	201,707	$37.94M	0.1%	+82.3%	0.371%
5/12/2022	Eagle Asset Management Inc.	341,995	$64.33M	0.3%	+8.2%	0.628%
5/12/2022	AlphaCrest Capital Management LLC	2,326	$0.44M	0.0%	-48.0%	0.004%
5/12/2022	PNC Financial Services Group Inc.	5,723	$1.08M	0.0%	+6.2%	0.011%
5/12/2022	Fiduciary Trust Co.	2,400	$0.45M	0.0%	+26.3%	0.004%
5/12/2022	Cetera Advisor Networks LLC	2,217	$0.42M	0.0%	-8.2%	0.004%
5/12/2022	Cetera Advisors LLC	1,609	$0.30M	0.0%	-20.4%	0.003%
5/12/2022	Oppenheimer Asset Management Inc.	23,954	$4.51M	0.1%	+18.1%	0.044%
5/12/2022	HighTower Advisors LLC	17,652	$3.33M	0.0%	+1.1%	0.032%
5/12/2022	Thornburg Investment Management Inc.	44,361	$8.34M	0.1%	-10.2%	0.082%
5/12/2022	1492 Capital Management LLC	5,623	$1.06M	0.6%	N/A	0.010%
5/12/2022	Cambridge Investment Research Advisors Inc.	3,286	$0.62M	0.0%	-40.0%	0.006%
5/12/2022	Cambridge Trust Co.	200	$38K	0.0%	N/A	0.000%
5/11/2022	Veritable L.P.	1,556	$0.29M	0.0%	+4.8%	0.003%
5/11/2022	Picton Mahoney Asset Management	1,655	$0.31M	0.0%	-69.9%	0.003%
5/11/2022	BMS Financial Advisors LLC	1,411	$0.27M	0.2%	+10.3%	0.003%
5/11/2022	US Bancorp DE	17,805	$3.35M	0.0%	+8.2%	0.033%
5/11/2022	American Century Companies Inc.	530,528	$99.79M	0.1%	+7.6%	0.975%
5/11/2022	Bank of New York Mellon Corp	849,212	$159.73M	0.0%	+12.0%	1.560%
5/11/2022	Johnson Investment Counsel Inc.	8,782	$1.65M	0.0%	N/A	0.016%
5/11/2022	Crossmark Global Holdings Inc.	4,390	$0.83M	0.0%	-7.0%	0.008%
5/11/2022	Coldstream Capital Management Inc.	2,117	$0.40M	0.0%	-11.4%	0.004%
5/11/2022	Raymond James Financial Services Advisors Inc.	1,917	$0.36M	0.0%	-13.3%	0.004%
5/11/2022	Handelsbanken Fonder AB	7,923	$1.49M	0.0%	-8.1%	0.015%
5/11/2022	Raymond James & Associates	67,622	$12.72M	0.0%	+72.1%	0.124%
5/11/2022	Primecap Management Co. CA	29,373	$5.53M	0.0%	+5.7%	0.054%
5/11/2022	Jennison Associates LLC	80,155	$15.08M	0.0%	-10.4%	0.147%

Data available starting January 2016

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $154.53

$150.09

$158.00

50 Day Range

MA: $165.24

$141.93

$191.43

52 Week Range

Now: $154.53

$137.21

$327.32

Volume

247,865 shs

Average Volume

508,798 shs

Market Capitalization

$8.41 billion

P/E Ratio

61.08

Dividend Yield

N/A

Beta

0.98

Who are the company insiders with the largest holdings of Repligen?: Repligen's top insider investors include:
Anthony Hunt (CEO)
Karen A Dawes (Director)
Karen A Dawes (Director)
Christine Gebski (Insider)
Jon Snodgres (CFO)
Ralf Kuriyel (VP)
James Bylund (SVP)
Thomas F Ryan Jr (Director)
Nicolas Barthelemy (Director)
Learn More about top insider investors at Repligen.
Who are the major institutional investors of Repligen?: Repligen's top institutional shareholders include:
Vanguard Group Inc. — 8.99%
Invesco Ltd. — 3.23%
WCM Investment Management LLC — 2.56%
State Street Corp — 2.54%
Select Equity Group L.P. — 1.73%
Bank of New York Mellon Corp — 1.56%
Learn More about top institutional investors of Repligen stock.
Which institutional investors are selling Repligen stock?: Within the last quarter, RGEN stock was sold by these institutional investors:
1832 Asset Management L.P.
Gilder Gagnon Howe & Co. LLC
The Manufacturers Life Insurance Company
First Trust Advisors LP
National Bank of Canada FI
Vanguard Group Inc.
SG Americas Securities LLC
Americana Partners LLC
During the last year, company insiders that have sold Repligen company stock include:
Anthony Hunt (CEO)
Karen A Dawes (Director)
Karen A Dawes (Director)
Christine Gebski (Insider)
Jon Snodgres (CFO)
Ralf Kuriyel (VP)
Learn More investors selling Repligen stock.
Which institutional investors are buying Repligen stock?: During the previous quarter, RGEN stock was bought by institutional investors including:
Conestoga Capital Advisors LLC
Echo Street Capital Management LLC
Natixis Advisors L.P.
Bank of New York Mellon Corp
Royce & Associates LP
Farallon Capital Management LLC
Congress Asset Management Co. MA
Invesco Ltd.

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

Get the Details Now.

RGEN Insider Trading (Repligen)

Repligen Insider Trading History Chart

Repligen Share Price & Price History

Repligen Insider Trading History

SEC Filings (Institutional Ownership Changes) for Repligen (NASDAQ:RGEN)

Institutional Buying and Selling by Quarter

Repligen Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Repligen?

Who are the major institutional investors of Repligen?

Which institutional investors are selling Repligen stock?

Which institutional investors are buying Repligen stock?